A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors. - Wikidata - wikimedia - TriplyDB

A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors.

A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors.

http://www.wikidata.org/entity/Q33418620

about

All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.

P2860

Q35884399-79A0C17A-2498-486F-9DE0-79F3CF9D7BE0 Q43156580-490096C3-4959-4241-956A-3AA84B6B4B8F

P2860

A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors.

http://www.wikidata.org/entity/Q33418620

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A novel trial of topotecan, if ...... n with recurrent solid tumors.

@ast

A novel trial of topotecan, if ...... n with recurrent solid tumors.

@en

type

label

A novel trial of topotecan, if ...... n with recurrent solid tumors.

@ast

A novel trial of topotecan, if ...... n with recurrent solid tumors.

@en

prefLabel

A novel trial of topotecan, if ...... n with recurrent solid tumors.

@ast

A novel trial of topotecan, if ...... n with recurrent solid tumors.

@en

P1433

Q33418620-809A9261-1E3B-45CC-BBE0-9D37A40F68F5

P1476

Q33418620-F6AFB780-9553-4175-A022-9F2890D70BF6

P2093

Q33418620-330DC198-988A-4D3A-94BC-E1A2F883343C

Q33418620-4F5DF27C-5FD8-48E4-91FF-430ECF4A725F

Q33418620-59DF2D3B-58C8-400F-9E9A-922E333D481E

Q33418620-63784F22-E4C9-4171-ABC5-B3DA7D67F39D

Q33418620-685A3E77-5BF8-47E1-9B75-0269724FBFB9

Q33418620-83E35D64-2129-4490-A7F8-A646A68CF2BE

Q33418620-89C1605E-14F3-4BB6-9ECE-6879C1C5497A

Q33418620-9C211C3F-3693-4CE7-BC62-0505EBD3AFF1

Q33418620-CE9BD0AF-CD26-412F-B761-86012516F8C7

Q33418620-D784C4FF-51E9-4DD9-BEC7-494770B56587

P2860

Q33418620-0088673E-B8C4-4EC1-961E-E5772C75C413

Q33418620-020CE54A-F487-4F8C-95A8-546C2E4B7CBE

Q33418620-0DC59A1E-8600-4D06-9E03-30475A4067DF

Q33418620-246D1E1C-7FA0-4130-827F-830FEC69B273

Q33418620-32D9D63D-3660-4C8B-8856-59EE2F8DBF79

Q33418620-337AB16F-91E3-421B-9FBB-251847ECA766

Q33418620-57E7925A-0EB3-4C1F-8F7A-638C036ABEF6

Q33418620-59A7AD8B-507F-405F-8AD5-F7DA013BD2A2

Q33418620-5BABA72E-8CA5-4841-BB2B-69DAE057F703

Q33418620-5DE0F25D-4C80-467A-915E-2909E668A06C

P304

Q33418620-BCA3AA20-739E-476E-8314-CF505B8CF0F6

P31

Q33418620-3D596E87-EC7A-478C-993E-75E85663EC99

P356

Q33418620-21AEF577-66C2-4C3E-9C24-8AA63995C45D

P433

Q33418620-C14D2B9D-7FF2-4954-8643-3DB969BB7C30

P478

Q33418620-C64E901B-36E1-466D-A22D-BF7B8D2010F4

P577

Q33418620-F274A16A-8A34-41E5-B0EF-7CD310A6EEDC

P5875

Q33418620-49DA5463-F23C-4888-AF70-B368CBCDF49B

P698

Q33418620-9F750CD6-3935-4081-949B-9BCAB4E02EEF

P356

P1433

Pediatric Blood & Cancer

P1476

A novel trial of topotecan, if ...... n with recurrent solid tumors.

@en

P2093

Alice Lee

http://www.w3.org/2001/XMLSchema#string

Erin Morris

http://www.w3.org/2001/XMLSchema#string

James H Garvin

http://www.w3.org/2001/XMLSchema#string

Johannes E Wolff

http://www.w3.org/2001/XMLSchema#string

Kavita Radhakrishnan

http://www.w3.org/2001/XMLSchema#string

Laura Gates

http://www.w3.org/2001/XMLSchema#string

Lauren A Harrison

http://www.w3.org/2001/XMLSchema#string

Mitchell S Cairo

http://www.w3.org/2001/XMLSchema#string

Robert J Wells

http://www.w3.org/2001/XMLSchema#string

Violet Shen

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

Subacute central nervous system degeneration in a child: an unusual manifestation of ifosfamide intoxication.

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Phase I pharmacologic study of oral topotecan and intravenous cisplatin: sequence-dependent hematologic side effects.

Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.

A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncolo

Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.

P304

274-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25309

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267984340

http://www.w3.org/2001/XMLSchema#string

P698

25382188

http://www.w3.org/2001/XMLSchema#string